Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

PHARMARON(03759.HK)

Event Tracking

Apr4

CMBI Reiterates Buy Rating on Kangbok Chemical H Shares

07:44

Apr1

Kanglong Chem 完成制剂车间建设并签订战略合作协议

09:08

Mar30

Canlon Chemicals Reports Revenue Growth but Net Profit Decline in 2025

12:03

PHARMARON released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue HKD 4.459 B (forecast HKD 4.427 B), actual EPS HKD 0.3243

11:00

PHARMARON released FY2025 Annual Earnings on March 30 After-Market (BJT), Actual Revenue HKD 15.41 B (Forecast HKD 15.57 B), Actual EPS HKD 1.0266 (Forecast HKD 1.1009)

11:00

Mar25

Kangbashi Establishes New Drug Production Company in Shaoxing

05:50

Schedules & Filings

Schedules

Filings

Apr29

Earning Release(CST)

FY2026 Q1 Earning Release

Mar30

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 4.459 B, Net Income 581.58 M, EPS 0.3243

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 3.984 B, Net Income 480.46 M, EPS 0.272

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

PHARMARON(03759.HK)

PHARMARON Stock Performance Chart

Trending